Stocklytics Platform
Asset logo for symbol MRK
Merck & Co
MRK69
$98.05arrow_drop_down1.40%-$1.39
S&P500
Asset logo for symbol MRK
MRK69

$98.05

arrow_drop_down1.40%

Performance History

Chart placeholder
Key Stats
Open$98.83
Prev. Close$99.52
EPS4.78
Next Earnings DateApr 11, 2025
LOWHIGH
Day Range98.00
99.66
52 Week Range94.67
134.63
Ratios
EPS4.78

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

About Merck & Co (MRK)

Merck & Co., Inc., also known as Merck Sharp & Dohme (MSD) outside of the United States and Canada, is a global pharmaceutical company that develops, manufactures, and markets a wide range of innovative health solutions. With a rich history spanning more than a century, Merck has become a leader in the discovery and development of medicines, vaccines, and animal health products.
Merck's mission is to strive for excellence in delivering healthcare solutions that improve and save lives. The company's commitment to innovation is evident in its diverse portfolio of products, which address some of the world's most pressing health challenges. From treatments for cancer and cardiovascular disease to vaccines for infectious diseases, Merck is dedicated to advancing global health.
One of Merck's key strengths lies in its robust research and development (R&D) pipeline. The company invests heavily in scientific innovation and has a strong track record of bringing breakthrough therapies to market. Merck's R&D efforts focus on areas such as oncology, immunology, infectious diseases, and vaccines. By staying at the forefront of biomedical research, Merck is able to deliver novel treatments that improve patient outcomes.
In addition to its pharmaceutical business, Merck is a major player in the animal health industry. Through its subsidiary, Merck Animal Health, the company develops and markets a wide range of products for the prevention and treatment of diseases in livestock and pets. By combining its expertise in human and animal health, Merck is able to provide integrated solutions that benefit both patients and their animal companions.
Merck's commitment to sustainability is another important aspect of its corporate identity. The company recognizes the need to address global health challenges in a way that is socially and environmentally responsible. Merck is actively engaged in initiatives aimed at improving access to healthcare, reducing its environmental impact, and enhancing the well-being of communities around the world. By prioritizing sustainability, Merck is able to create long-term value for its stakeholders while making a positive impact on society.
In summary, Merck & Co., Inc. is a global pharmaceutical company that is dedicated to improving and saving lives through its innovative health solutions. With a strong focus on research and development, Merck delivers breakthrough therapies that address some of the world's most critical health challenges. Through its animal health division and sustainability initiatives, the company extends its impact beyond human health. Merck's commitment to excellence, innovation, and sustainability positions it as a leading player in the healthcare industry.
Merck & Co., Inc. (MRK) is a global pharmaceutical company that develops, manufactures, and markets a wide range of health solutions for both human and animal health. The company, also known as Merck Sharp & Dohme (MSD) outside of the United States and Canada, has a rich history of over a century and is committed to improving and saving lives.
With a mission to deliver excellence in healthcare, Merck focuses on research, innovation, and collaboration to address some of the world's most pressing health challenges. The company's diverse portfolio includes medicines, vaccines, biologic therapies, and animal health products.
Merck's key strength lies in its robust research and development (R&D) pipeline. The company invests heavily in scientific innovation and has a track record of bringing cutting-edge therapies to market. By focusing on areas such as oncology, immunology, infectious diseases, and vaccines, Merck contributes to advancements in global health.
In addition to its pharmaceutical business, Merck is a leader in the animal health industry. Its subsidiary, Merck Animal Health, develops and markets products for livestock and pets, contributing to the well-being of animals worldwide.
Merck's commitment to sustainability is integrated into its corporate identity. The company aims to create long-term value while considering the social and environmental impact of its operations. By engaging in initiatives that improve access to healthcare, reduce carbon emissions, and support communities, Merck demonstrates its dedication to sustainable business practices.
In conclusion, Merck & Co., Inc. is a global pharmaceutical company dedicated to improving and saving lives through its innovative health solutions. With its strong emphasis on research, collaboration, and sustainability, Merck continues to be a leader in the healthcare industry, addressing global health challenges and creating value for patients, animals, and communities worldwide.
Websitecall_made
Sector
Healthcare
Industry
Drug Manufacturers—General
CEO
Mr. Robert M. Davis J.D.
Headquarters
Rahway
Employees
67000
Exchange
NYSE
add Merck & Co to watchlist

Keep an eye on Merck & Co

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Merck & Co 's (MRK) price per share?

The current price per share for Merck & Co (MRK) is $98.05. The stock has seen a price change of -$1.4 recently, indicating a -1.41% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Merck & Co (MRK)?

For Merck & Co (MRK), the 52-week high is $134.63, which is 37.31% from the current price. The 52-week low is $94.67, the current price is 3.57% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Merck & Co (MRK) a growth stock?

Merck & Co (MRK) has shown an average price growth of -4.38% over the past three years. It has received a score of 66 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Merck & Co as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Merck & Co (MRK) stock price performance year to date (YTD)?

As of the latest data, Merck & Co (MRK) has a year-to-date price change of -13.41%. Over the past month, the stock has experienced a price change of 0.63%. Over the last three months, the change has been -16.32%. Over the past six months, the figure is -24.38%. Looking at a longer horizon, the five-year price change stands at 7.06%.
help

Is Merck & Co (MRK) a profitable company?

Merck & Co (MRK) has a net income of $365M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 73.17% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 26.2% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $60.12B, with a revenue growth rate of 1.4%, providing insight into the company's sales performance and growth. The gross profit is $43.99B. Operating income is noted at $2.95B. Furthermore, the EBITDA is $7.54B.
help

What is the market capitalization of Merck & Co (MRK)?

Merck & Co (MRK) has a market capitalization of $248.03B. The average daily trading volume is 98.51, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level